Duchenne muscular dystrophy (DMD) is a disease that damage smuscles, causing 
muscle weakness and loss of the ability to walk.  DMD is most common in boys.   
Domagrozumab isanexperimental medicine studied for DMD.  Domagrozumab has 
not been approved for use outside of research studies.
The main goal of this study was to learn more about the long-term safety of 
domagrozumab in boys with DMD. Researchers wanted to answer thisquestion : 
What medical problems did boys have during the study?
To ans wer this question, researchers looked at:
Medical problems that caused the boyto temporarily stop taking 
domagrozumab , or that caused the dose of domagrozumab to be lowered
How severe medical problems were, whether the medic al problems were 
related to taking domagrozumab, and whether boys needed to leave the study 
because of the medical problems
Lab test findings
Findings from p hysical examination, x -rays, andother tests